Tg Therapeutics (TGTX) Leases (2019 - 2025)
Historic Leases for Tg Therapeutics (TGTX) over the last 7 years, with Q3 2025 value amounting to $6.5 million.
- Tg Therapeutics' Leases fell 1227.9% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 1227.9%. This contributed to the annual value of $7.2 million for FY2024, which is 1116.77% down from last year.
- As of Q3 2025, Tg Therapeutics' Leases stood at $6.5 million, which was down 1227.9% from $6.7 million recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Leases peaked at $9.1 million during Q1 2021, and registered a low of $6.5 million during Q3 2025.
- Over the past 5 years, Tg Therapeutics' median Leases value was $8.5 million (recorded in 2023), while the average stood at $8.2 million.
- Its Leases has fluctuated over the past 5 years, first surged by 336.21% in 2022, then plummeted by 1238.3% in 2025.
- Quarter analysis of 5 years shows Tg Therapeutics' Leases stood at $8.6 million in 2021, then increased by 3.0% to $8.9 million in 2022, then fell by 9.43% to $8.0 million in 2023, then fell by 11.17% to $7.2 million in 2024, then dropped by 9.09% to $6.5 million in 2025.
- Its Leases stands at $6.5 million for Q3 2025, versus $6.7 million for Q2 2025 and $6.9 million for Q1 2025.